Development of inhaled vancomycin for treatment of mrsa infections in CF
Ended Project Grant Awarded Last action
- Award ID
- R44HL112393
- Recipient
-
Aravas Inc. UEI HDD4ZCLWT1K6
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $3,986,098
Award facts
- Assistance listing
- 93.838 Lung Diseases Research
- Completion date
- Place of performance
- Austin, TX 78746, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,015,080 | |
| Amendment | $1,680,649 | |
| Original award | $1,290,369 |
Quick answers
Who received award R44HL112393?
R44HL112393 was awarded to Aravas Inc. by National Institutes of Health (Department of Health and Human Services) on March 1, 2013.
How much is award R44HL112393 worth?
$3,986,098 has been obligated on R44HL112393.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award